Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EIF4EBP2P3 is a processed pseudogene (retrocopy) of the protein-coding gene eukaryotic translation initiation factor 4E binding protein 2 (EIF4EBP2). Pseudogenes like EIF4EBP2P3 are DNA sequences that arose by duplication or retrotransposition of functional genes but lost the ability to encode a functional protein due to disabling mutations. The majority of pseudogenes do not produce functional proteins and are considered nonfunctional "genomic fossils." Rarely, some pseudogenes may have regulatory functions at the RNA level (such as producing noncoding RNAs that influence gene expression), but specific biological roles are generally not assigned unless experimentally validated, which is not the case for EIF4EBP2P3. Consequently, this pseudogene is not considered a direct target for drug development or disease therapy.
None relevant; pseudogenes are generally not acted upon by drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4E binding protein 2 pseudogene 3 (EIF4EBP2P3).